R&D Facts

Be in the know. Discover important facts and figures about global health research and development.

Infographic Data Sources

Global pipeline for neglected diseases

All data: Chapman N. The unrecognised revolution in global health. Sydney: Policy Cures; 2015.

Funding for neglected disease R&D

$265 billion global spending on all health R&D: Røttingen, J-E, Regmi, S, Eide, M et al. Mapping of available health research and development data: what's there, what's missing and what role is there for a global observatory. Lancet. 2013; 383:1286–1307 [Data is for total global spending on health R&D in the year 2009, the most recent year available. The amount has been adjusted to 2015 dollars.]

$3.63 billion global spending on neglected disease R&D/Neglected disease R&D spending by sector: Chapman N, Abela-Oversteegen L, et al. Neglected Disease Research and Development: A Pivotal Moment for Global Health. G-FINDER | 2016. Sydney: Policy Cures; 2017. [Data reflects R&D funding for 'traditional' neglected diseases as defined by the 2016 G-FINDER, as well as Ebola and other African viral hemorrhagic fevers.]

Neglected disease R&D spending by sector: Moran M, Chapman N, Abela-Oversteegen L, et al. Neglected Disease Research and Development: The Ebola Effect. G-FINDER | 2015. Sydney: Policy Cures; 2015.

Return on investment in global health R&D

New health innovations resulted in 4.2 million fewer child deaths: Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014.

Antiretroviral therapies prevented 7.6 million deaths: UNAIDS. The Gap Report. Geneva: UNAIDS; 2014.

11% of economic growth in low-and middle-income countries: Jamison DT, Summers LH, Alleyne G, et al. Global health 2035: a world converging within a generation. The Lancet. 2013;382(9908):1859– 1861.

Malaria costs African countries $12 billion a year: Gallup JL, Sachs JD. The economic burden of malaria. The American Journal of Tropical Medicine and Hygiene. 2001; vol. 64, 1 suppl: 85-96.

The average TB patient loses 3-4 months of work: Fonko PN. Pricing infectious disease: The economic and health implications of infectious diseases. EMBO Reports. 2008. 2 suppl. 1: S13-S17.

$26 million invested in polio vaccine R&D: Thompson KM, Tebbens RJ Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Anal. 2006; 26(6):1423–40.

Every $1 invested in HIV vaccine R&D: Hecht R, Jamison DT. Vaccine research and development assessment paper In: Lomborg B, ed. Rethink HIV: smarter ways to invest in ending HIV in sub-Saharan Africa. New York: Cambridge University Press, 2012; 299–320.

New TB treatment regimens under development: Global Health Technologies Coalition, Policy Cures. Saving lives and creating impact: Why investing in global health research works. Sydney: Policy Cures; 2012.

$.89 of every dollar spent by US government: Early findings from Policy Cures/GHTC analysis to be published in spring 2017.

€.80 of every euro of EU investment: Policy Cures, Deutsche Stiftung Weltbevoelkerung. Saving lives: Making the case for European investment in poverty-related and neglected disease R&D. Sydney: Policy Cures; 2016.

Ongoing need

1 billion people affected by neglected diseases: World Health Organization (WHO). Investing to Overcome the Global Impact of Neglected Tropical Diseases: Third WHO Report on Neglected Tropical Diseases. Geneva: WHO; 2015.

6 million annual deaths from neglected diseases: Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2010 (GBD 2010) Results by Cause and by Region 1990-2010. 2013.

225 million women have unmet family planning needs: Singh S, Darroch JE and Ashford LS. Adding It Up: The Costs and Benefits of Investing in Sexual and Reproductive Health 2014, New York: Guttmacher Institute, 2014.

Critical US role in global health R&D

55% of products in the global health pipeline/<01% of us em>: Global Health Technologies Coalition, Policy Cures. Saving lives and creating impact: Why investing in global health research works. Sydney: Policy Cures; 2012.

46% of total investment in global health R&D/73% of public sector investment in global health R&D: Chapman N, Abela-Oversteegen L, et al. Neglected Disease Research and Development: A Pivotal Moment for Global Health. G-FINDER | 2016. Sydney: Policy Cures; 2017. [Data reflects R&D funding for 'traditional' neglected diseases as defined by the 2016 G-FINDER, as well as Ebola and other African viral hemorrhagic fevers.]

Top public funders of neglected disease R&D

All data: Chapman N, Abela-Oversteegen L, et al. Neglected Disease Research and Development: A Pivotal Moment for Global Health. G-FINDER | 2016. Sydney: Policy Cures; 2017. [Data reflects R&D funding for only 'traditional' neglected diseases as defined by the 2016 G-FINDER.]